Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms.
Ratings
4.8 / 5
13 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. August J. Troendle$12.4B
Market Cap • 06/05/20242014
(há 10 anos)
2016
(8 years ago)
NASDAQ
Listagem
Cincinnati
Sede • Ohio5.400
N° de Empregados • 2023Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
MEDPSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.